article4 May 2018 | By Graham Clark - TraceLink, Liam O'Riordan - Enterprise System Partners
Developing serialisation programmes is a key concern for pharmaceutical companies. Much of the decision-making is being driven by fast-approaching deadlines for compliance - both in the EU and US.